Literature DB >> 2138261

Deposition of amyloid (A4) protein within the brains of persons with dementing disorders other than Alzheimer's disease and Down's syndrome.

D M Mann1, D Jones.   

Abstract

Deposition of amyloid (A4) protein was assessed in the cerebral cortex of 26 patients dying with various neurodegenerative disorders, other than Alzheimer's disease. Amyloid deposits were (variably) present in 2/3 (66%) elderly (i.e. over 65 years of age) patients with progressive supranuclear palsy, 4/7 (57%) with Parkinson's disease, 2/5 (40%) with Huntington's chorea and in both elderly patients with frontal lobe dementia but were only rarely seen in any patient before this age. The A4 protein deposits were nearly always of a diffuse type with only an occasional 'cored' neuritic plaque being present. Amyloid deposition in elderly persons may thus relate more to certain aspects of ageing and genetics than to AD, per se. Only in this latter condition are the cerebral cortical amyloid deposits widely associated with a neuritic change and a neurofibrillary degeneration of nerve cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138261     DOI: 10.1016/0304-3940(90)90539-l

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  A case of progressive supranuclear palsy with widespread senile plaques.

Authors:  S Sasaki; S Maruyama; C Toyoda
Journal:  J Neurol       Date:  1991-09       Impact factor: 4.849

2.  Deposition of amyloid beta protein in non-Alzheimer dementias: evidence for a neuronal origin of parenchymal deposits of beta protein in neurodegenerative disease.

Authors:  D M Mann; D Jones; P W South; J S Snowden; D Neary
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth.

Authors:  E H Koo; L Park; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

Review 4.  Alzheimer disease.

Authors:  Rudy J Castellani; Raj K Rolston; Mark A Smith
Journal:  Dis Mon       Date:  2010-09       Impact factor: 3.800

5.  The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease.

Authors:  D M Mann; D Jones; D Prinja; M S Purkiss
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project.

Authors:  Elizabeth E Blue; Joshua C Bis; Michael O Dorschner; Debby W Tsuang; Sandra M Barral; Gary Beecham; Jennifer E Below; William S Bush; Mariusz Butkiewicz; Carlos Cruchaga; Anita DeStefano; Lindsay A Farrer; Alison Goate; Jonathan Haines; Jim Jaworski; Gyungah Jun; Brian Kunkle; Amanda Kuzma; Jenny J Lee; Kathryn L Lunetta; Yiyi Ma; Eden Martin; Adam Naj; Alejandro Q Nato; Patrick Navas; Hiep Nguyen; Christiane Reitz; Dolly Reyes; William Salerno; Gerard D Schellenberg; Sudha Seshadri; Harkirat Sohi; Timothy A Thornton; Otto Valadares; Cornelia van Duijn; Badri N Vardarajan; Li-San Wang; Eric Boerwinkle; Josée Dupuis; Margaret A Pericak-Vance; Richard Mayeux; Ellen M Wijsman
Journal:  Dement Geriatr Cogn Disord       Date:  2018-02-27       Impact factor: 2.959

7.  Analysis of staining methods for different cortical plaques in Alzheimer's disease.

Authors:  G Halliday; D Flowers; L Baum
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

8.  Cerebral beta amyloid deposition in patients with malignant neoplasms: its prevalence with aging and effects of radiation therapy on vascular amyloid.

Authors:  S Sugihara; A Ogawa; Y Nakazato; H Yamaguchi
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Achromatic neurons in the cortex of progressive supranuclear palsy.

Authors:  I R Mackenzie; L P Hudson
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus.

Authors:  R S Desikan; A J Schork; Y Wang; A Witoelar; M Sharma; L K McEvoy; D Holland; J B Brewer; C-H Chen; W K Thompson; D Harold; J Williams; M J Owen; M C O'Donovan; M A Pericak-Vance; R Mayeux; J L Haines; L A Farrer; G D Schellenberg; P Heutink; A B Singleton; A Brice; N W Wood; J Hardy; M Martinez; S H Choi; A DeStefano; M A Ikram; J C Bis; A Smith; A L Fitzpatrick; L Launer; C van Duijn; S Seshadri; I D Ulstein; D Aarsland; T Fladby; S Djurovic; B T Hyman; J Snaedal; H Stefansson; K Stefansson; T Gasser; O A Andreassen; A M Dale
Journal:  Mol Psychiatry       Date:  2015-02-17       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.